TIP39 inhibitors encompasses a variety of compounds that indirectly modulate the activity or effects of TIP39, primarily through their action on related signaling pathways and cellular processes. TIP39, or the tuberoinfundibular peptide of 39 residues, is a neuropeptide that primarily interacts with the parathyroid hormone 2 receptor (PTH2R). Unlike typical protein targets for small molecule inhibitors, TIP39 does not directly bind with most chemical inhibitors. Instead, the inhibition is achieved indirectly by influencing pathways or receptors that are either directly or tangentially associated with TIP39's physiological roles. This class of inhibitors includes a diverse range of chemicals, each with unique mechanisms of action, affecting various biological processes like bone remodeling, neuromodulation, cell proliferation, and stress responses.
The complexity and diversity of TIP39 inhibitors reflect the multifaceted nature of the biochemical pathways involved in TIP39's activities. For instance, some inhibitors in this class target the BMP (bone morphogenetic protein) pathway, which has implications for bone physiology, a process in which TIP39 is known to play a role. Others may target signaling pathways like mTOR, MEK, or PI3K, which are involved in fundamental cellular processes like growth, proliferation, and survival. By modulating these pathways, TIP39 inhibitors can indirectly affect the functional outcomes of TIP39. This indirect mechanism of action is a hallmark of this chemical class, distinguishing it from inhibitors that directly target specific protein structures. The versatility of TIP39 inhibitors lies in their ability to influence a range of signaling cascades and cellular mechanisms, shedding light on the interconnected nature of cellular signaling networks and the complex interplay of neuropeptides like TIP39 within these networks.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclopentolate | 512-15-2 | sc-358109 sc-358109A | 100 mg 1 g | $222.00 $1012.00 | ||
An anticholinergic agent that blocks muscarinic receptors. It may influence TIP39's role in neuromodulation indirectly by altering cholinergic neurotransmission. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
A BMP (bone morphogenetic protein) pathway inhibitor. This chemical can indirectly affect TIP39 by influencing BMP signaling, which intersects with pathways regulated by PTH2R. | ||||||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
A potent BMP inhibitor, similar to Dorsomorphin, and can influence pathways indirectly associated with TIP39. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, known for its role in cell growth and proliferation. It indirectly affects pathways that could intersect with TIP39's functions. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor, which can modulate stress response pathways, potentially influencing TIP39 activity indirectly. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, which affects various cellular processes, potentially intersecting with TIP39-regulated pathways. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
An inhibitor of the TGF-β receptor, which could indirectly influence TIP39 by modulating TGF-β signaling pathways. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, affecting cytoskeletal dynamics. This may indirectly influence TIP39's neuromodulatory roles. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
An adenylyl cyclase activator, indirectly affecting cAMP levels and pathways potentially associated with TIP39. | ||||||